Pages that link to "Q34326780"
Jump to navigation
Jump to search
The following pages link to Canine hemophilia B resulting from a point mutation with unusual consequences (Q34326780):
Displaying 50 items.
- Animal models of hemophilia (Q27012571) (← links)
- Current animal models of hemophilia: the state of the art (Q28072423) (← links)
- Man's best friend becomes biology's best in show: genome analyses in the domestic dog (Q28730686) (← links)
- Lessons Learned from Animal Models of Inherited Bleeding Disorders (Q30409863) (← links)
- The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion (Q30745198) (← links)
- Translational Data from AAV-Mediated Gene Therapy of Hemophilia B in Dogs (Q30882233) (← links)
- Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs (Q30891500) (← links)
- von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis (Q33391519) (← links)
- Platelets and coagulation. An update (Q33497247) (← links)
- Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs (Q33671665) (← links)
- Gene therapy for the hemophilias (Q33723486) (← links)
- Gene therapy for hemophilia. (Q33838660) (← links)
- Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B. (Q33931862) (← links)
- Applications of genetic engineering in veterinary medicine (Q34019859) (← links)
- Safety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogs. (Q34025098) (← links)
- Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. (Q34126365) (← links)
- Gene therapy: a 2001 perspective (Q34176027) (← links)
- Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B. (Q34343757) (← links)
- Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium? (Q34368127) (← links)
- Mutation discovery for Mendelian traits in non-laboratory animals: a review of achievements up to 2012. (Q34478523) (← links)
- Portal vein delivery of viral vectors for gene therapy for hemophilia (Q34795284) (← links)
- Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. (Q34994506) (← links)
- Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency (Q35006603) (← links)
- Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B. (Q35006608) (← links)
- Adeno-associated virus-mediated gene transfer for hemophilia B. (Q35015540) (← links)
- In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs (Q35109095) (← links)
- AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice (Q35153203) (← links)
- Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia (Q35157358) (← links)
- Nutritional Genomics: Implications for Companion Animals (Q35547517) (← links)
- Novel reporter systems for facile evaluation of I-SceI-mediated genome editing (Q35672279) (← links)
- New findings on animal diseases published since 2003. 1. Dogs (Q35741259) (← links)
- The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots (Q35843460) (← links)
- Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model (Q35847459) (← links)
- Understanding hereditary diseases using the dog and human as companion model systems (Q36021334) (← links)
- Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B. (Q36085401) (← links)
- Large animal models and gene therapy (Q36333340) (← links)
- Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test - Demonstrated in vitro and ex vivo (Q36337979) (← links)
- Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. (Q36438711) (← links)
- The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy. (Q36440058) (← links)
- In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions (Q37056724) (← links)
- Animal models of hemophilia and related bleeding disorders (Q37091290) (← links)
- A web resource on DNA tests for canine and feline hereditary diseases (Q37189238) (← links)
- Leader of the pack: gene mapping in dogs and other model organisms (Q37247556) (← links)
- The Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis (Q37348229) (← links)
- Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII. (Q37354951) (← links)
- Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model (Q37357517) (← links)
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges (Q37866086) (← links)
- Gene therapy for haemophilia: a long and winding road. (Q37903924) (← links)
- Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapies (Q38754256) (← links)
- Liver-Directed Adeno-Associated Viral Gene Therapy for Hemophilia (Q39553052) (← links)